Baird Medical Investment Holdings Ltd
BDMD1.390USD
-0.020-1.42%
收盤 12/19, 16:00（美東）報價延遲15分鐘
36.91M總市值
虧損本益比TTM
關於 Baird Medical Investment Holdings Ltd 公司
Baird Medical Investment Holdings Ltd is a company mainly engaged in the microwave ablation medical device business. The Company is mainly engaged in the provision of microwave ablation medical device. The medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps.
Baird Medical Investment Holdings Ltd簡介
公司代碼BDMD
公司名稱Baird Medical Investment Holdings Ltd
上市日期Dec 13, 2021
CEOWu (Haimei)
員工數量143
證券類型Ordinary Share
年結日Dec 13
公司地址18/F, Ovest
城市GUANGZHOU
上市交易所NASDAQ OMX - NASDAQ BASIC
國家China
郵編- -
電話
網址https://ir.bairdmed.com/
公司代碼BDMD
上市日期Dec 13, 2021
CEOWu (Haimei)
Baird Medical Investment Holdings Ltd公司高管
名稱
名稱/職務
職務
持股
持股變動
Ms. Haimei Wu
Ms. Haimei Wu
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
18.30M
--
Mr. Joe Ragan
Mr. Joe Ragan
Director
Director
--
--
Prof. Mingzhao (Michael) Xing
Prof. Mingzhao (Michael) Xing
Independent Director
Independent Director
--
--
Mr. Lijian Xu
Mr. Lijian Xu
Independent Director
Independent Director
--
--
Mr. Rongjian Lu
Mr. Rongjian Lu
Chief Technology Officer, Deputy General Manager
Chief Technology Officer, Deputy General Manager
--
--
Ms. Jie Li
Ms. Jie Li
Acting Chief Financial Officer
Acting Chief Financial Officer
--
--
Mr. Wei Hou
Mr. Wei Hou
Director
Director
--
--
Mr. Jin Xu
Mr. Jin Xu
Quality Assurance Department Manager
Quality Assurance Department Manager
--
--
Mr. Wei Xu
Mr. Wei Xu
Merchandising Department Manager
Merchandising Department Manager
--
--
Mr. Robin Yang
Mr. Robin Yang
Investor Relations
Investor Relations
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Ms. Haimei Wu
Ms. Haimei Wu
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
18.30M
--
Mr. Joe Ragan
Mr. Joe Ragan
Director
Director
--
--
Prof. Mingzhao (Michael) Xing
Prof. Mingzhao (Michael) Xing
Independent Director
Independent Director
--
--
Mr. Lijian Xu
Mr. Lijian Xu
Independent Director
Independent Director
--
--
Mr. Rongjian Lu
Mr. Rongjian Lu
Chief Technology Officer, Deputy General Manager
Chief Technology Officer, Deputy General Manager
--
--
Ms. Jie Li
Ms. Jie Li
Acting Chief Financial Officer
Acting Chief Financial Officer
--
--
收入明細
單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2024
FY2023
業務USD
名稱
營收
佔比
MWA Needles
33.83M
91.33%
MWA Therapeutic Apparatus
3.20M
8.64%
Other Medical Devices
9.83K
0.03%
地區USD
名稱
營收
佔比
China (Mainland)
37.04M
100.00%
業務
地區
業務USD
名稱
營收
佔比
MWA Needles
33.83M
91.33%
MWA Therapeutic Apparatus
3.20M
8.64%
Other Medical Devices
9.83K
0.03%
股東統計
更新時間: 11月20日 週四
更新時間: 11月20日 週四
持股股東
股東類型
持股股東
持股股東
佔比
Wu (Haimei)
71.59%
ExcelFin SPAC LLC
18.68%
Grand Fortune Capital (H.K.) Co, Ltd.
9.65%
Periscope Capital
0.49%
Highbridge Capital Management, LLC
0.49%
持股股東
持股股東
佔比
Wu (Haimei)
71.59%
ExcelFin SPAC LLC
18.68%
Grand Fortune Capital (H.K.) Co, Ltd.
9.65%
Periscope Capital
0.49%
Highbridge Capital Management, LLC
0.49%
股東類型
持股股東
佔比
Individual Investor
71.59%
Corporation
28.32%
Investment Advisor/Hedge Fund
0.78%
Hedge Fund
0.67%
Investment Advisor
0.32%
Research Firm
0.05%
機構持股
更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
34
465.80K
9.90%
--
2025Q3
47
465.80K
18.84%
-72.37K
2025Q2
50
538.17K
21.64%
+180.74K
2025Q1
80
357.43K
67.10%
-16.79M
2024Q4
85
305.49K
75.32%
+42.45K
2024Q3
88
263.04K
299.72%
-979.92K
2024Q2
90
1.24M
285.03%
-389.76K
2024Q1
94
1.63M
272.11%
-20.00M
2023Q4
94
1.73M
289.40%
-2.99M
2023Q3
93
4.71M
469.75%
-226.48K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Wu (Haimei)
18.30M
71.59%
+18.30M
--
May 13, 2025
ExcelFin SPAC LLC
4.77M
18.68%
-976.59K
-16.98%
May 13, 2025
Grand Fortune Capital (H.K.) Co, Ltd.
2.46M
9.65%
+2.46M
--
May 13, 2025
Periscope Capital
125.00K
0.49%
--
--
Jun 30, 2025
Highbridge Capital Management, LLC
125.00K
0.49%
--
--
Jun 30, 2025
UBS Financial Services, Inc.
91.45K
0.36%
+34.51K
+60.61%
Jun 30, 2025
Northern Trust Investments, Inc.
52.44K
0.21%
+52.44K
--
Jun 30, 2025
Geode Capital Management, L.L.C.
25.44K
0.1%
+9.51K
+59.70%
Jun 30, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
常見問題
Baird Medical Investment Holdings Ltd的前五大股東是誰？
Baird Medical Investment Holdings Ltd的前五大股東如下：
Wu (Haimei)持有股份：18.30M佔總股份比例：71.59%。
ExcelFin SPAC LLC持有股份：4.77M佔總股份比例：18.68%。
Grand Fortune Capital (H.K.) Co, Ltd.持有股份：2.46M佔總股份比例：9.65%。
Periscope Capital持有股份：125.00K佔總股份比例：0.49%。
Highbridge Capital Management, LLC持有股份：125.00K佔總股份比例：0.49%。
Wu (Haimei)持有股份：18.30M佔總股份比例：71.59%。
ExcelFin SPAC LLC持有股份：4.77M佔總股份比例：18.68%。
Grand Fortune Capital (H.K.) Co, Ltd.持有股份：2.46M佔總股份比例：9.65%。
Periscope Capital持有股份：125.00K佔總股份比例：0.49%。
Highbridge Capital Management, LLC持有股份：125.00K佔總股份比例：0.49%。
Baird Medical Investment Holdings Ltd的前三大股東類型是什麼？
Baird Medical Investment Holdings Ltd 的前三大股東類型分別是：
Wu (Haimei)
ExcelFin SPAC LLC
Grand Fortune Capital (H.K.) Co, Ltd.
Wu (Haimei)
ExcelFin SPAC LLC
Grand Fortune Capital (H.K.) Co, Ltd.
有多少機構持有Baird Medical Investment Holdings Ltd(BDMD)的股份？
截至2025Q4，共有34家機構持有Baird Medical Investment Holdings Ltd的股份，合計持有的股份價值約為465.80K，占公司總股份的9.90% 。與2025Q3相比，機構持股有所增加，增幅為-8.94%。
哪個業務部門對Baird Medical Investment Holdings Ltd的收入貢獻最大？
在FY2024，MWA Needles 業務部門對Baird Medical Investment Holdings Ltd的收入貢獻最大，創收33.83M，占總收入的91.33% 。
